Biopharma Stock Breaking News – BioNTech (Nasdaq: BNTX) and DualityBio Receive FDA Fast Track Designation

MAINZ, Germany and SHANGHAI, China – January 31, 2024 ( Newswire) BioNTech SE (Nasdaq: BNTX”) and Duality Biologics (Suzhou) Co., Ltd. (“DualityBio”) today announced that the U.S. Food and Drug Administration (“FDA”) granted Fast Track designation for BNT325/DB-1305 for the treatment of patients with platinum-resistant ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer … Read more